Troponin In Carotid Revascularization - Trial NCT05293067
Access comprehensive clinical trial information for NCT05293067 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Belgrade and is currently Not yet recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 240 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Belgrade
Timeline & Enrollment
N/A
Apr 01, 2022
Apr 01, 2024
Primary Outcome
The incidence of myocardial injury,The incidence of myocardial injury,The incidence of myocardial infarction,The incidence of myocardial infarction,The rate of cardiac-related death,The rate of cardiac-related death,The incidence of stroke,The incidence of stroke,The rate of all-cause mortality,The rate of all-cause mortality
Summary
Patients undergoing carotid revascularization procedures are at increased risk for the
 development of short- and long-term cardiac complications. Increased values of high-sensitive
 troponin may be useful in a timely selection of those patients. Still, contemporary
 literature doesn't provide enough data to answer the following questions: Can high-sensitive
 troponin predict adverse cardiac outcomes perioperatively in carotid surgery?, Should these
 cardiac biomarkers be routinely sampled in all patients undergoing carotid
 revascularization? and Can elevated levels of high-sensitive troponin preoperatively
 designate patients in whom the risk of surgical treatment (at a given moment) is greater than
 the benefit of the surgery?.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05293067
Non-Device Trial